글로벌 암 지원 치료 약물 시장 - 업계 동향 및 2028년까지의 예측

시장 분석 및 통찰력: 글로벌 암 지원 치료 약물 시장

암 지원 치료 약물 시장은 2021-2028년 예측 기간에 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에서 언급한 예측 기간에 1.85%의 CAGR로 성장할 것으로 예측하여 시장을 분석합니다.

여러 유형의 암을 완화하는 데 사용되는 지지 치료는 생존율과 삶의 질을 향상시킵니다. 암 지지 치료는 암 치료 및 치료의 부정적인 결과로부터 환자를 구제하는 것을 목표로 합니다. 암 관련 부작용 및 이에 수반되는 부작용은 지지 암 치료 약물의 도움으로 예방하고 치료할 수 있습니다. 빈혈 , 메스꺼움, 구토 및 식욕 부진은 모두 암 치료의 부작용입니다. 지지 치료에 사용되는 약물 중 일부는 라스부리카제, 메스나, 폴린산, 덱스라조산 알로푸리놀 및 아미포스틴입니다. 다국적 암 지지 치료 협회는 저위험 발열성 호중구 감소증이 있는 개인을 식별하기 위한 채점 기준을 개발했습니다.

암 유병률의 증가와 항암 치료의 부작용으로 고통받는 사람들의 수의 증가는 시장 성장을 주도하는 주요 요인입니다. 또한 바이오시밀러 약물의 소비 증가, 의료 인프라의 개발, 정부와 민간 기관의 인식 프로그램 확산 및 공식화를 위한 이니셔티브 증가는 암 지원 치료 약물 시장을 확대할 요인입니다.

2021~2028년 예측 기간 동안 연구 개발 활동과 신흥 시장의 증가는 암 지원 치료 약물 시장에 유익한 기회를 제공할 것입니다.

그러나 암 지지 치료 약물과 관련된 높은 약물 비용과 부작용은 시장 성장을 방해하는 요소이며, 엄격한 규칙과 규정은 위에 언급한 예측 기간 동안 암 지지 치료 약물 시장에 어려움을 줄 것입니다.

This cancer supportive care drugs market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cancer supportive care drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Cancer Supportive Care Drugs Market Scope and Market Size

The cancer supportive care drugs market is segmented on the basis of cancer type, therapeutic class, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of cancer type, the cancer supportive care drugs market is segmented into lung cancer, prostate cancer, breast cancer, melanoma and others.
• On the basis of therapeutic class, the cancer supportive care drugs market is segmented into bisphosphonates, opioids, anti-emetics, nonsteroidal anti-inflammatory drug (NSAIDs), erythropoiesis stimulating agents (ESAs), granulocyte-colony stimulating factors (G-CSFs) and others.  Others have been further sub-segmented into antineoplastic antibiotics and neutropenia.
• On the basis of end-users, the cancer supportive care drugs market is segmented into clinic, hospital and others.
• The cancer supportive care drugs market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Cancer Supportive Care Drugs Market Country Level Analysis

The cancer supportive care drugs market is segmented on the basis of cancer type, therapeutic class, end-users and distribution channel.

The countries covered in the cancer supportive care drugs market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the cancer supportive care drugs market due to the presence of major key players, growing prevalence of cancer, high disposable income, high healthcare expenditure and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector, emergence of small players and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Cancer supportive care drugs market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Cancer Supportive Care Drugs Market Share Analysis

Cancer supportive care drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global cancer supportive care drugs market research.

암 지원 치료 약물 시장 보고서에서 다루는 주요 기업으로는 Amgen Inc., Novartis AG, Merck Sharp & Dohme Corp., Johnson & Johnson Private Limited, F. Hoffmann-La Roche Ltd, Helsinn Healthcare SA, Heron Therapeutics, Inc., GlaxoSmithKline plc, Purdue Pharma LP, Baxter, Fagron, Teva Pharmaceuticals Industries Ltd., APR, Kyowa Kirin Co., Ltd., Acacia Pharma Group Plc 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-47995